The recent study published in The Lancet Regional Health – Southeast Asia highlights a significant improvement in the timely initiation of cancer treatment in India,…
View More Ayushman Bharat’s impact on cancer treatment in IndiaLancet study
Covaxin Safe, Highly Immunogenic In Children, Says Study
NEW DELHI: Bharat Biotech’s Covaxin has proven to be ‘safe, well-tolerated, and highly immunogenic’ in children in Phase II/III studies, the results of which are…
View More Covaxin Safe, Highly Immunogenic In Children, Says Study